- Glidden, David;
- Wong, Joseph;
- Grant, Robert;
- Liegler, T;
- Abdel-Mohsen, M;
- Bentley, LG;
- Atchison, R;
- Schmidt, T;
- Javier, J;
- Mehrotra, M;
- Eden, C;
- Glidden, DV;
- McMahan, V
© The Author 2014.Background: The iPrEx study demonstrated that combination oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) as preexposure prophylaxis (PrEP) protects against HIV acquisition in men who have sex with men and transgender women
